Anica Högner

Myoglobin facilitates angiotensin II-induced constriction of renal afferent arterioles

Z. Z. Liu, Susanne Mathia, Tamara Margit Jutta Pahlitzsch et al. · American Journal of Physiology-Renal Physiology · 2017 · 43 citations · Full text

Medicine, Nephrology, Bioavailability +12

PBRM1 and VHL expression correlate in human clear cell renal cell carcinoma with differential association with patient’s overall survival

Anica Högner, Hans Krause, Burkhard Jandrig et al. · Urologic Oncology Seminars and Original Investigations · 2017 · 39 citations

Medicine, Cancer Biology, Oncology +12

Pazopanib with <scp>5‐FU</scp> and oxaliplatin as first line therapy in advanced gastric cancer: A randomized <scp>phase‐II</scp> study—The <scp>PaFLO</scp> trial. A study of the Arbeitsgemeinschaft Internistische Onkologie <scp>AIO‐STO</scp>‐0510

Anica Högner, Salah‐Eddin Al‐Batran, Jens T. Siveke et al. · International Journal of Cancer · 2021 · 22 citations · Full text

Medicine, Oncology, Pharmacology +17

The zinc-finger transcription factor SALL4 is frequently expressed in human cancers: association with clinical outcome in squamous cell carcinoma but not in adenocarcinoma of the esophagus

Ergin Kilic, Pierre Tennstedt, Anica Högner et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 2016 · 14 citations

Medicine, Cancer Biology, Oncology +13

Ramucirumab, Avelumab, and Paclitaxel as Second-Line Treatment in Esophagogastric Adenocarcinoma

Peter Thuss‐Patience, Anica Högner, Eray Goekkurt et al. · JAMA Network Open · 2024 · 13 citations · Full text

Medicine, Oncology, Pharmacology +17